Updated
Updated · ScienceAlert · Aug 17
Scientists Identify 3rd Hypertension Driver, Test 17b Drug That Lowers Blood Pressure in Mice
Updated
Updated · ScienceAlert · Aug 17

Scientists Identify 3rd Hypertension Driver, Test 17b Drug That Lowers Blood Pressure in Mice

3 articles · Updated · ScienceAlert · Aug 17

Summary

  • Compound 17b lowered blood pressure in hypertensive mice and also reduced aortic stiffness plus fibrosis in the heart and kidneys, pointing to benefits beyond standard pressure control.
  • The study identifies inflammation-resolution pathways as a third major hypertension driver alongside the sympathetic nervous system and RAAS hormone system.
  • Rather than broadly suppressing immunity, 17b activates formylpeptide receptors that signal the immune system to stand down, aiming to stop chronic inflammation more precisely.
  • Researchers said the mouse-only findings could support a complementary treatment for patients who cannot use existing drugs, but human studies are still needed.

Insights

If arterial stiffness and fibrosis matter as much as pressure, should future hypertension treatment target immune repair as well as RAAS and nerves?
Could a drug that barely lowers blood pressure still protect the heart, kidneys, and arteries by switching inflammation off naturally?